| Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More | Frank Vinluan | 01/03/20 | National |
| Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More | Sarah de Crescenzo | 12/20/19 | National |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink | Frank Vinluan | 12/11/19 | National |
| Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More | Sarah de Crescenzo | 12/06/19 | National |
| Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal | Frank Vinluan | 12/03/19 | San Francisco |
| A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns | Melissa Fassbender | 12/03/19 | National |
| Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More | Frank Vinluan | 11/22/19 | National |
| Biopharma Execs Remain Optimistic Despite Political Headwinds | Mike Ward | 11/20/19 | National |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio | Sarah de Crescenzo | 11/15/19 | San Diego |
| Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange | Frank Vinluan | 11/11/19 | San Francisco |
| Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
| AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund | Gareth Macdonald | 11/06/19 | National |
| GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site | Dan Stanton | 11/06/19 | National |
| Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More | Frank Vinluan | 11/01/19 | National |
| FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns | Frank Vinluan | 10/30/19 | National |
| Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More | Sarah de Crescenzo | 10/25/19 | National |
| SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study | Sarah de Crescenzo | 10/21/19 | Seattle |
| Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More | Frank Vinluan | 10/18/19 | National |
| Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices | Jeff Bauter Engel | 10/17/19 | Boston |
| Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More | Frank Vinluan | 10/11/19 | San Francisco |
| Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More | Alex Lash | 10/11/19 | National |
| The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? | Alex Lash | 10/10/19 | National |
| Five Years After Y Combinator First Admits Biotechs, They’re Dug In | Bernadette Tansey | 10/09/19 | San Francisco |
| Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels | Frank Vinluan | 10/07/19 | National |
| Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates | Jeff Bauter Engel | 10/04/19 | Wisconsin |
| Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More | Ben Fidler | 10/04/19 | National |
| Icosavax Lands $51M to Bring Vaccine for Respiratory Virus to Clinic | Frank Vinluan | 10/03/19 | Seattle |
| Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto | Bernadette Tansey | 10/02/19 | San Francisco |
